The Clorox Co. (CLX)

156.28
NYSE : Consumer Non-Durables
Prev Close 156.28
Day Low/High 0.00 / 0.00
52 Wk Low/High 113.57 / 167.70
Avg Volume 1.03M
Exchange NYSE
Shares Outstanding 128.16M
Market Cap 20.03B
EPS 6.40
P/E Ratio 25.83
Div & Yield 3.84 (2.46%)

Latest News

The Difference Between a Luxury and a Necessity: Cramer's 'Mad Money' Recap

The Difference Between a Luxury and a Necessity: Cramer's 'Mad Money' Recap

Jim Cramer looks at what's changed in people's views of life's essentials.

Jim Cramer: These Products Are Essential to Corporations and Your Portfolio

Jim Cramer: These Products Are Essential to Corporations and Your Portfolio

These firms offer complex hardware and software solutions that empower the modern-day corporation.

(Photo: Business Wire)

(Photo: Business Wire)

Burt's Bees, a leading provider of personal care products committed to natural health and beauty solutions, today announced that the Journal of Drugs in Dermatology has published clinical data supporting the efficacy and tolerability of Burt's Bees skin...

Clorox Declares Regular Quarterly Dividend Of 96 Cents Per Share

Clorox Declares Regular Quarterly Dividend Of 96 Cents Per Share

OAKLAND, Calif., Feb.

Estee Lauder Is Poised to Break Out to New Highs

Estee Lauder Is Poised to Break Out to New Highs

Estee Lauder is relying more on celebrity influencers to expand the reach of its brand.

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Jim Cramer says Wednesday brought multiple positive earnings surprises that prompt us to ask how is it possible that these moves can occur without warning?

Jim Cramer: If You Don't Buy Google, You Are Dying on the Vine

Jim Cramer: If You Don't Buy Google, You Are Dying on the Vine

This quarter will be known as the quarter where you had to pay the piper to get sales and the piper happens most often to be Alphabet's Google.

Can Clorox Stock Continue to Clean Up?

Can Clorox Stock Continue to Clean Up?

Our latest strategy after checking the charts and indicators.

Own These, Don't Trade Them: Cramer's 'Mad Money' Recap

Own These, Don't Trade Them: Cramer's 'Mad Money' Recap

Jim Cramer looks at the recent action in Apple and a few other tech winners, and says everyone who dumped them now has seller's remorse.

Stocks Rise Ahead of Alphabet Earnings

Stocks Rise Ahead of Alphabet Earnings

Stocks rose Monday amid another rush of earnings reports this week including Alphabet results due after the bell.

Clorox Stock Becoming a Buy on Earnings Beat

Clorox Stock Becoming a Buy on Earnings Beat

Clorox stock is flying higher after beating second-quarter estimates. Could be time to buy it.

Clorox Tops Q2 Earnings Estimate, Confirms 2019 Outlook

Clorox Tops Q2 Earnings Estimate, Confirms 2019 Outlook

Clorox posted stronger-than-expected second quarter earnings Monday, and confirmed its full-year profit outlook but noted that trade tariffs will hit its bottom line.

What the Super Bowl Can Teach Us About Our Portfolio: Market Recon

What the Super Bowl Can Teach Us About Our Portfolio: Market Recon

And why maintaining a small position in defense stocks is important.

Google, Trump, General Motors, New England Patriots - 5 Things You Must Know

Google, Trump, General Motors, New England Patriots - 5 Things You Must Know

U.S. stock futures rise modestly as investors focus on stronger-than-expected jobs and manufacturing data from the United States last week; Google parent Alphabet reports earnings Monday after the closing bell; Donald Trump says there's a 'good chance' of a trade deal with China; the New England Patriots win their sixth Super Bowl title.

The Week Ahead: Alphabet, Disney and 12 Other Big Earnings Reports to Watch

The Week Ahead: Alphabet, Disney and 12 Other Big Earnings Reports to Watch

Buckle up after Super Sunday.

Bulls vs. Bears: Cramer's 'Mad Money' Recap (Friday 2/1/19)

Bulls vs. Bears: Cramer's 'Mad Money' Recap (Friday 2/1/19)

Jim Cramer makes sense of this market action and has your game plan for next week.

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

This Market's Holding Up: Cramer's 'Mad Money' Recap (Monday 1/28/19)

Jim Cramer takes a closer look at today's pin action, and talks about why the weakness didn't spread.

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

CVS Health, Neogenomics, Vicor: 'Mad Money' Lightning Round

Jim Cramer weighs in on CVS Health, Neogenomics, Vicor, WD-40, T. Rowe Price, Clorox and more.

LA Cat Lovers Unite At The Cats On Glass Gallery In Los Angeles

LA Cat Lovers Unite At The Cats On Glass Gallery In Los Angeles

Interactive Pop-up with a Purpose Presented by Fresh Step® Clean Paws™ Partners with spcaLA, Kitten Lady and Nala Cat to Encourage More Cat Adoptions

Let’s Talk About the Resistance Overhead Today

Because If we don’t we would be the only people NOT talking about it!

Catnip Dreams Meet Instagram Inspiration At The Cats On Glass Gallery In Los Angeles

Catnip Dreams Meet Instagram Inspiration At The Cats On Glass Gallery In Los Angeles

Interactive Pop-up with a Purpose Presented by Fresh Step® Clean Paws™ Partners with spcaLA, Kitten Lady and Nala Cat to Encourage More Cat Adoptions

Keep an Eye on Earnings: Cramer's 'Mad Money' Recap (Thursday 1/3/19)

Keep an Eye on Earnings: Cramer's 'Mad Money' Recap (Thursday 1/3/19)

Jim Cramer says a trade deal could help, but what matters after today is earnings -- and how bad the shortfalls will be.

Jim Cramer: What Matters After Today Is Earnings

Jim Cramer: What Matters After Today Is Earnings

A trade deal with China could certainly help as well.

Jim Cramer: They Might Be Done

Jim Cramer: They Might Be Done

Whether this is the end of the slump is still up for debate, but the crash since October has been brutal and all bear markets end the same way.

Jim Cramer: Jay Powell Is a Nightmare for President Trump and Stock Buyers

Jim Cramer: Jay Powell Is a Nightmare for President Trump and Stock Buyers

5 key things investors need to know about their portfolios and how to proceed after the Fed's disappointing announcement.

TheStreet Quant Rating: B+ (Buy)